B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy;Pseudolinfoma B inducido por hidróxido de aluminio tras tratamiento hiposensibilizante

Actas Dermo-Sifiliograficas

Volumn 99, Issue 3, 2008, Pages 213-216

  Hernandez I ^a   Sanmartín, Onofre ^b   Carda C ^c   Gomez S ^d   Alfaro, A ^b  

^a Hospital General Básico de la Defensa de Valencia   (Spain)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c Hospital Clinico de Valencia   (Spain)

^d NONE

Author keywords

Aluminium hydroxide; B cell pseudolymphoma; Subcutaneous nodules

Indexed keywords

ALUMINUM HYDROXIDE; ANTIHISTAMINIC AGENT; CD20 ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; B CELL PSEUDOLYMPHOMA; B LYMPHOCYTE; CASE REPORT; CHROMOSOME TRANSLOCATION; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION; FEMALE; HISTIOCYTE; HUMAN; HUMAN TISSUE; HYPERTRICHOSIS; IMMUNOTHERAPY; PSEUDOLYMPHOMA; SUBCUTANEOUS NODULE; X RAY MICROANALYSIS;

EID: 41949083057     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(08)70234-8     Document Type: Article

References (16)

1. Culora GA, Ramsay AD, Theaker JM. Aluminium and injection site reactions. J Clin Pathol. 1996;49:844-7.
2. Maubec E, Pinquier L, Viguier M, Caux F, Amsler E, Aractingi S, et al. Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol. 2005;52:623-9.
3. Kaaber K, Nielsen AO, Veien NK. Vaccination granulomas and aluminium allergy: course and prognostic factors. Contact Dermatitis. 1992;26:304-6.
4. Frost L, Johansen P, Pedersen S, Veien N, Ostergaard PA, Nielsen MH. Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy. 1985;40:368-72.
5. Vogelbruch M, Nuss B, Korner M, Kapp A, Kiehl P, Bohm W. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy. 2000;55:883-7.
6. Lin J, Zhang J, Dong X, Fang H, Chen J, Su N, et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet. 2006;368:991-7.
7. Authier FJ, Sauvat S, Christov C, Chariot P, Raisbeck G, Poron MF, et al. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background. Neuromuscul Disord. 2006;16:347-52.
8. García-Patos V, Pujol RM, Alomar A, Cistero A, Curell R, Fernández-Figueras MT, et al. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts. Arch Dermatol. 1995;131:1421-4.
9. Bergfors E, Trollfors B, Inerot A. Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer. Vaccine. 2003;22:64-9.
10. Burg G, Kempf W, Cozzio A, Feit J, Willemze R, E SJ, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32:647-74.
11. Chong H, Brady K, Metze D, Calonje E. Persistent nodules at injection sites (aluminium granuloma) - clinicopathological study of 14 cases with a diverse range of histological reaction patterns. Histopathology. 2006;48:182-8.
12. García-Patos V, Alomar A, Lleonart R, Cistero A, Matías-Guiu X. [Subcutaneous nodules and sensitivity to aluminum in patients undergoing hyposensitivity immunotherapy]. Med Cutan Ibero Lat Am. 1990;18:83-8.
13. Morroni M, Barbatelli G, Carboni V, Sbarbati A, Cinti S. Subcutaneous nodules in a patient hyposensitized with aluminium-containing allergen extracts: a microanalytical study. Anal Cell Pathol. 1995;9:235-41.
14. Nagore E, Martínez-Escribano JA, Tato A, Sabater V, Vilata JJ. Subcutaneous nodules following treatment with aluminium-containing allergen extracts. Eur J Dermatol. 2001;11:138-40.
15. Sangueza OP, Yadav S, White CR Jr., Braziel RM. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am J Dermatopathol. 1992;14:408-13.
16. Mikasa K, Watanabe D, Kondo C, Tamada Y, Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol. 2005;53:911-2.